On Tuesday, Palisade Bio Inc (NASDAQ: PALI) opened higher 4.97% from the last session, before settling in for the closing price of $1.81. Price fluctuations for PALI have ranged from $0.53 to $3.30 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 77.35% over the past five years. Company’s average yearly earnings per share was noted 93.18% at the time writing. With a float of $139.74 million, this company’s outstanding shares have now reached $149.00 million.
Palisade Bio Inc (PALI) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Palisade Bio Inc is 6.22%, while institutional ownership is 28.40%.
Palisade Bio Inc (PALI) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.69 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.99) by 1.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 93.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.44% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Check out the current performance indicators for Palisade Bio Inc (PALI). In the past quarter, the stock posted a quick ratio of 1.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.22, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Palisade Bio Inc (NASDAQ: PALI) saw its 5-day average volume 4.6 million, a positive change from its year-to-date volume of 3.04 million. As of the previous 9 days, the stock’s Stochastic %D was 28.71%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 71.35%, which indicates a significant increase from 31.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1978 in the past 14 days, which was higher than the 0.1744 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8643, while its 200-day Moving Average is $1.0357. Nevertheless, the first resistance level for the watch stands at $2.0200 in the near term. At $2.1400, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2850. If the price goes on to break the first support level at $1.7550, it is likely to go to the next support level at $1.6100. Assuming the price breaks the second support level, the third support level stands at $1.4900.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
There are currently 149,003K shares outstanding in the company with a market cap of 283.11 million. Presently, the company’s annual sales total 0 K according to its annual income of -14,440 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -2,870 K.
